To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With Dyslipidemia
Clinical trial NCT04155645 · COMPLETED
Trial details
- NCT number
- NCT04155645
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2021-06-07
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.